SCHEMBL22604398

SCHEMBL22604398

OCc1ccc(Br)cc1CCl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.43
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
NPC1 O15118 3/20 0.36
CHEK1 O14757 1/20 0.34
ALDH1A1 P00352 5/20 0.34
MAPK1 P28482 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RAB9A P51151 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TSHR P16473 1/20 0.33
GFER P55789 1/20 0.33
ALOX15 P16050 1/20 0.33
SLC6A3 Q01959 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31185057 1.00 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL19582282 0.91 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL795719 0.86 PTGDR2 (0.48) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL29417721 0.86 PTGDR2 (0.48) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL1561687 0.86 CYP2A6 (0.35) PTGDR2ALDH1A1MAPK1TSHRGFER
SCHEMBL15653274 0.80 PYCR1 (0.32) PTGDR2TSHRGFERALOX15
SCHEMBL8128901 0.80 PTGDR2 (0.44) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL23275220 0.78 SMN1; SMN2 (0.39) ALDH1A1MAPK1LMNAMAPTRAB9A
SCHEMBL30219182 0.78 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1CHEK1
SCHEMBL24102707 0.78 PTGDR2 (0.43) PTGDR2SLC6A2SLC6A4NPC1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020216240-A1 DICYCLIC ALKANE COMPOUND USEFUL AS INHIBITOR OF PLASMA KALLIKREIN 南京明德新药研发有限公司 2020-10-29 WO disclosed